This deliverable reports on the development of a Decision Tool aimed at identifying the key processes and procedures for engagement with regulatory, HTA bodies, and payers at key points in the development of an asset. The tool will help the IMI ND projects in identifying the most appropriate procedures and ways in which they can interact with different stakeholders, based on the project’s stage of research and type of asset being developed. This will help ensure that the outputs being developed by projects that are part of the IMI Neurodegeneration portfolio are relevant for regulatory and HTA settings, where applicable.
D3.3 First version of regulatory/HTA/payer interaction decision tool
